Global reporting of cases of COVID‐19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic
- 10 June 2020
- journal article
- letter
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 183 (2), 404-406
- https://doi.org/10.1111/bjd.19161
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Comparative safety of systemic immunomodulatory medications in adults with atopic dermatitisJournal of the American Academy of Dermatology, 2021
- Baricitinib for COVID-19: a suitable treatment?The Lancet Infectious Diseases, 2020
- European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitisJournal of the European Academy of Dermatology and Venereology, 2020
- COVID-19: immunopathology and its implications for therapyNature Reviews Immunology, 2020
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJama-Journal Of The American Medical Association, 2020
- Atopic dermatitisNature Reviews Disease Primers, 2018
- Update on psoriasis immunopathogenesis and targeted immunotherapySeminars in Immunopathology, 2015
- Risk of Serious Infection With Biologic and Systemic Treatment of PsoriasisJAMA Dermatology, 2015